Clinical trial
Critical Illness Among Recipients of Hematopoietic Cell Transplantation (CARE-HCT): a Prospective, Multicenter Observational Study in China
NCT07328724 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Critical Illness Among Recipients of Hematopoietic Cell Transplantation (CARE-HCT): a Prospective, Multicenter Observational Study in China
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2026
- Completion date
- December 31, 2036
- Enrollment
- 4,000 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, hematopoetic stem cell transplantation, transplant complication, ventilated patients